Thomas Eiwegger

Thomas Eiwegger is an Associate Professor at Karl Landsteiner University of Health Sciences and an Adjunct Professor in the Department of Immunology at the University of Toronto. He serves as Head of the Clinical Department of Pediatrics and Adolescent Medicine at St. Pölten University Hospital and leads research groups at both the Hospital for Sick Children (SickKids) in Toronto and Karl Landsteiner University. His academic and clinical work integrates pediatric allergy, immunology, and translational research.

• Karl Landsteiner University of Health Sciences – Associate Professor, Scientific Working Group Clinical Immunology
• University of Toronto – Adjunct Professor, Department of Immunology
• St. Pölten University Hospital – Head, Clinical Department of Pediatrics and Adolescent Medicine
• Hospital for Sick Children (SickKids) – Adjunct Scientist, Translational Medicine Program

Dr. Eiwegger's research focuses on the immunological mechanisms of food allergy and asthma in children, with a strong emphasis on immune tolerance, diagnostic innovation, and novel therapies such as oral and epicutaneous immunotherapy. His lab develops human in vitro models of the gut to study allergic responses at the cellular level. He has published over 140 peer-reviewed articles, primarily in top-tier allergy and immunology journals, with consistent output through 2025. His work frequently involves investigator-initiated trials and collaborations across North America and Europe.

The recent publications demonstrate a clear trend toward clinical translation, with studies on biologics, anaphylaxis biomarkers, and long-term cohort research such as the PreCareFemCohort. His expertise is recognized through editorial roles at Allergy and leadership in the Biologics Working Group of EAACI. He has received multiple scientific awards, including the Science Prize of the State of Lower Austria in 2023 and 2024.

• Science Prize of the State of Lower Austria (2024)
• Science Prize for the best experimental work (2023)
• Associate Editor, Allergy
• Chair, Biologics Working Group, EAACI

Dr. Eiwegger supervises PhD students, Master’s students, and clinical fellows, contributing significantly to academic training in allergy and immunology. He is the Principal Investigator (PI) or Co-PI on multiple funded projects, including DARC2 (Danube Allergy Research Cluster), IFAM (Initial Immune Mechanisms in Food Allergy), and biomarker studies in childhood anaphylaxis. His work aims to establish St. Pölten as a leading center for pediatric allergy and clinical research in Austria.

He is actively involved in establishing research infrastructure, including clinical trial centers and collaborative networks such as the Danube Allergy Research Cluster. His work bridges clinical practice and academic research, ensuring that scientific advancements directly benefit patient care.